课题基金 / 基金详情

Covalent host targeting by thioester domains of Gram-positive pathogens

Covalent host targeting by thioester domains of Gram-positive pathogens
革兰氏阳性病原体硫酯结构域的共价宿主靶向
批准号:
MR/K001485/1
负责人:
Ulrich Schwarz-Linek
金额:
$87.5万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Ulrich Schwarz-Linek的其他基金

相似基金

相关文献

中文摘要
翻译
细菌感染是医学和科学最重要的挑战之一。对几乎所有已知抗生素具有耐药性的细菌的出现对全球健康构成威胁。人们普遍认识到对新抗菌药物的迫切需求,但在过去几十年中很少有人推出。为了开发出与青霉素等已知药物明显不同的治疗方法,我们需要更好地了解细菌引起感染的方式。首先,细菌需要在人体内站稳脚跟。这是通过存在于细菌表面的各种分子实现的。这些分子,大多数是专门的蛋白质,通常形成称为皮利的毛发状结构,与细菌进入人体的部位(如喉咙,气道,牙龈,肠道,皮肤)的人体细胞结合。一旦细菌设法附着在人体细胞上,它们要么存活并繁殖,要么通过进入细胞侵入宿主,从而最终在体内传播。如果有可能阻止细菌与人体细胞结合,那么就有可能在早期阶段干预感染。我们的研究发现了一种特别有趣的机制,细菌可能会利用这种机制快速而紧密地与人体细胞结合。这与已知的细菌结合模式相比,如强力胶与尼龙搭扣相比。重要的是,这种新的结合机制似乎被一些最重要的人类病原体所共享。这些包括细菌肺炎链球菌(也称为肺炎球菌),这是英国和全世界肺炎的最重要原因。它还引起一种形式的脑膜炎和败血症(血液中毒),在发展中国家,五岁以下儿童所有可预防的死亡中有四分之一是由这种疾病造成的。肺炎球菌疾病在医院环境和社区中非常常见,并且存在问题,因为细菌对许多抗生素具有耐药性。其他使用超胶样结合机制的细菌是肺炎球菌的亲戚。化脓性链球菌引起包括猩红热和链球菌性咽喉炎在内的多种疾病,影响着全世界数亿人。这些细菌也可能导致严重的后续疾病。其中,风湿性心脏病(RHD)是印度和其他发展中国家儿童和青少年的最大杀手之一。化脓性链球菌可以像肺炎球菌一样产生抗生素耐药性,这将导致产褥热或风湿性心脏病等危险疾病的重新出现。我们亦预测,很多引致牙龈疾病或牙齿脱落的细菌,都能产生强力胶蛋白,使细菌能紧紧地黏在牙齿表面和牙龈上。我们建议研究“细菌分子强力胶”的分子细节。我们需要确定细菌制造的关键蛋白质的精确结构,以了解它们如何攻击人类细胞。为了实现这一目标,我们将结合使用两种强大的方法,NMR光谱学和X射线晶体学,以原子细节揭示细菌蛋白质的结构。同时,我们将确定人体细胞的哪些成分作为细菌的结合靶点。这将通过使用细菌蛋白质作为分子诱饵,在模型人类细胞(在细胞培养物中生长)上或中钓取它们的结合伴侣来实现。一旦确定了目标,我们将确定细菌蛋白质如何准确识别人类细胞成分。这些信息将使我们能够设计出能够与细菌蛋白特异性反应的小分子,从而为新的诊断工具和抗菌物质奠定基础。我们将联合收割机结合我们的分子研究和使用细菌的实验,以找出是否失去了对细菌至关重要的强力胶功能,使它们不那么有效地入侵人体。
英文摘要
Bacterial infections represent one of the most important challenges for medicine and science. The emergence of bacteria resistant to almost all known antibiotics is a threat to global health. The urgent need for new antibacterial drugs is widely recognised but very few have been introduced in the last couple of decades. In order to develop treatments that differ significantly from known drugs like penicillin we need to understand better the ways in which bacteria cause infections. To start with, bacteria need to gain a foothold in the human body. This is achieved through a variety of molecules present on the bacterial surface. These molecules, mostly specialised proteins that often form hairlike structures called pili, bind to human cells found at the site of bacterial entry into the body (e.g. throat, airways, gums, guts, skin). Once bacteria manage to cling to human cells they either survive and multiply or they invade their host by entering cells, thus eventually spreading in the body. If it was possible to prevent the bacteria from binding to human cells, it would be possible to intervene with infections at an early stage.Our research has uncovered a particularly intriguing mechanism that bacteria may use to bind rapidly and very tightly to human cells. This compares to known bacterial binding modes like superglue compares to Velcro. Importantly this new binding mechanism appears to be shared by some of the most important human pathogens. These include the bacterium Streptococcus pneumoniae (also known as pneumococcus), which is the most important cause of pneumonia in the UK and worldwide. It also causes a form of meningitis and septicaemia (blood poisoning), which in developing countries is responsible for one quarter of all preventable deaths in children under five. Pneumococcal diseases are very common in hospital settings and in the community and are problematic because the bacteria are resistant to many antibiotics. Other bacteria using the superglue-like binding mechanism are relatives of pneumococci. Streptococcus pyogenes causes a wide range of conditions including scarlet fever and strep throat, affecting hundreds of millions of people worldwide. These bacteria can also cause severe follow-on diseases. Of these, rheumatic heart disease (RHD) is one of the biggest killers of children and youths in India and other developing nations. Streptococcus pyogenes could develop antibiotic resistance just like the pneumococci did, which would result in the re-emergence of dangerous diseases like childbed fever or RHD. We also predict that many of the bacteria causing gum disease or teeth loss will be able to produce superglue proteins which may enable bacteria to very tightly stick to teeth surfaces and gums.We propose to study the molecular details of the "bacterial molecular superglue". We need to determine the precise architecture of the critical proteins made by the bacteria in order to understand how they attack human cells. To achieve this, we will use a combination of two powerful methods, NMR spectroscopy and X-ray crystallography, to reveal the structures of the bacterial proteins in atomic detail. At the same time we will determine which components of human cells serve as binding targets for the bacteria. This will be accomplished by using the bacterial proteins as molecular bait, fishing for their binding partners on or in model human cells (grown in cell culture). Once the targets have been identified we will establish how exactly the bacterial proteins recognise human cell components. This information will allow us to design small molecules that would specifically react with bacterial proteins, thus forming the basis for new diagnostic tools and antimicrobial substances. We will combine our molecular studies with experiments using bacteria in order to find out if a loss of the critical superglue function on bacteria makes them less efficient invaders of the human body.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
The proline-rich repeat and thioester domains of streptococcal fibronectin-binding proteins
链球菌纤连蛋白结合蛋白富含脯氨酸的重复结构域和硫酯结构域
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [Kan Su-Yin]
通讯作者: Kan Su-Yin
Covalent host-targeting by thioester domains of Gram-positive pathogens
革兰氏阳性病原体硫酯结构域的共价宿主靶向
DOI: 10.1107/s2053273314091517
发表时间: 2014
期刊: Acta Crystallographica Section A Foundations and Advances
影响因子: --
作者: [Walden M]
通讯作者: Walden M
DOI: 10.7554/elife.06638
发表时间: 2015-06-02
期刊: eLife
影响因子: 7.7
作者: [Walden M, Edwards JM, Dziewulska AM, Bergmann R, Saalbach G, Kan SY, Miller OK, Weckener M, Jackson RJ, Shirran SL, Botting CH, Florence GJ, Rohde M, Banfield MJ, Schwarz-Linek U]
通讯作者: Schwarz-Linek U
DOI: 10.1002/pro.3478
发表时间: 2018-09
期刊: Protein science : a publication of the Protein Society
影响因子: --
作者: [Miller OK, Banfield MJ, Schwarz-Linek U]
通讯作者: Schwarz-Linek U
Molecular basis for Rift Valley fever phlebovirus NSs protein function
  • 批准号:
    MR/W018608/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $103.59万
  • 财政年份:
    2022
  • 负责人:
    Ulrich Schwarz-Linek
  • 依托单位:
A molecular basis for autoimmune sequelae of streptococcal infections
  • 批准号:
    MR/N009681/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $73.93万
  • 财政年份:
    2016
  • 负责人:
    Ulrich Schwarz-Linek
  • 依托单位:
国内基金
海外基金
lncRNA-HOST2—USP15—VGLL4轴促进乳腺癌肝转移的机制研究
  • 批准号:
    82073204
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    房林
  • 依托单位:
新鉴定PA-X“host-shutoff”功能区调控H7N9禽流感病毒毒力的机制
  • 批准号:
    32072832
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    胡娇
  • 依托单位:
能量代谢触发植入干细胞和损伤视网膜细胞Graft-to Host细胞间通讯/物质交换及命运转变的机制
溶液加工型多层磷光器件的组装与性能优化